SELLAS Life Sciences Group, Inc.
Hedge Funds Holdings
Last updated:
SELLAS Life Sciences Group, Inc.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 11.27% of the total amount of its stocks outstanding. This makes up a total of 2.18M shares of SELLAS Life Sciences Group, Inc.. Compared to the previous quarter, the number grew by 15.73% or 297.27K shares more. As for the holding position changes, 30.77% (4) of current hedge fund investors increased the number of shares held, 7.69% (1) of current holders sold a part of the shares held, and 46.15% (6) closed the holdings completely. 2 hedge funds are new holders of SELLAS Life Sciences Group, Inc. stock in Q1 2023, it is 15.38% of total holders.
Hedge funds holding SELLAS Life Sciences Group (Q2 2018 – Q1 2023)
Q2 2018 | 13 |
---|---|
Q3 2018 | 13 |
Q4 2018 | 16 |
Q1 2019 | 10 |
Q2 2019 | 15 |
Q3 2019 | 15 |
Q4 2019 | 9 |
Q1 2020 | 10 |
Q2 2020 | 12 |
Q3 2020 | 10 |
Q4 2020 | 17 |
Q1 2021 | 28 |
Q2 2021 | 28 |
Q3 2021 | 29 |
Q4 2021 | 26 |
Q1 2022 | 26 |
Q2 2022 | 23 |
Q3 2022 | 25 |
Q4 2022 | 27 |
Q1 2023 | 13 |
Hedge funds changes in SELLAS Life Sciences Group positions (Q2 2018 – Q1 2023)
Q2 2018 | 2 | 6 | 1 | 1 | 3 |
---|---|---|---|---|---|
Q3 2018 | 5 | 4 | 0 | 5 | -1 |
Q4 2018 | 7 | 6 | 1 | 4 | -2 |
Q1 2019 | 1 | 4 | 2 | 7 | -4 |
Q2 2019 | 6 | 5 | 2 | 1 | 1 |
Q3 2019 | 6 | 3 | 2 | 6 | -2 |
Q4 2019 | 9 | 0 | 0 | 15 | -15 |
Q1 2020 | 4 | 3 | 1 | 2 | 0 |
Q2 2020 | 5 | 1 | 2 | 3 | 1 |
Q3 2020 | 3 | 2 | 3 | 5 | -3 |
Q4 2020 | 9 | 3 | 2 | 2 | 1 |
Q1 2021 | 14 | 7 | 3 | 3 | 1 |
Q2 2021 | 5 | 13 | 5 | 5 | 0 |
Q3 2021 | 7 | 11 | 6 | 6 | -1 |
Q4 2021 | 5 | 5 | 8 | 8 | 0 |
Q1 2022 | 4 | 8 | 8 | 4 | 2 |
Q2 2022 | 7 | 10 | 2 | 9 | -5 |
Q3 2022 | 5 | 4 | 6 | 4 | 6 |
Q4 2022 | 11 | 9 | 2 | 8 | -3 |
Q1 2023 | 2 | 4 | 1 | 6 | 0 |
Hedge funds changes in SELLAS Life Sciences Group stock options (Q2 2018 – Q1 2023)
Q2 2018 | 489,000 | 11,000 |
---|---|---|
Q3 2018 | 164,000 | 4,000 |
Q4 2018 | 166,000 | 4,000 |
Q1 2019 | 64,000 | 0 |
Q2 2019 | 7,000 | 0 |
Q3 2019 | 8,000 | 0 |
Q4 2019 | 269,000 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 370,000 | 0 |
Q1 2021 | 2,406,000 | 2,074,000 |
Q2 2021 | 3,981,000 | 2,011,000 |
Q3 2021 | 3,189,000 | 1,309,000 |
Q4 2021 | 2,314,000 | 607,000 |
Q1 2022 | 1,976,000 | 1,052,000 |
Q2 2022 | 1,515,000 | 224,000 |
Q3 2022 | 1,369,000 | 141,000 |
Q4 2022 | 2,003,432 | 71,384 |
Q1 2023 | 294,884,000 | 5,294,000 |